Sintilimab, a PD-1 Inhibitor, Completely Reversed Rarely Refractory Hypofibrinogenemia in a Gastric Cancer Patient: A Case Report and Review of the Literature

While cancer is often related to hyperfibrinogenemia, it is rarely related to hypofibrinogenemia. Specifically, gastric cancer concomitant with unprovoked hypofibrinogenemia and the corresponding treatment approach have been rarely reported. We presented a case of gastric cancer in a 78-year-old Chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Shuzhen, Dang, Qi, Yang, Yali, Liu, Yongliang, Sun, Yuping, Sun, Meili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604326/
https://www.ncbi.nlm.nih.gov/pubmed/33194584
http://dx.doi.org/10.3389/fonc.2020.526096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604326/
https://www.ncbi.nlm.nih.gov/pubmed/33194584
http://dx.doi.org/10.3389/fonc.2020.526096

Ejemplares similares